Comparing the current results to its competitors, Xbiotech Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 11.8 %, recorded in the same quarter.
Xbiotech Inc , slower than the average decrease reported by the company's competitors of -59.11 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -59.11 %
January 4, 2024
XBiotech Inc., a leading biotechnology company based in Austin, Texas, has set its sights on significant growth with the announcement of plans to construct a state-of-the-art research and development facility. The company has received approval from the City of Austin and is set to commence excavation and site preparation for this groundbreaking project in the first quarter of 2024.The decision to expand the XBiotech campus headquarters and invest in a new RandD facility underscores the company s commitment to innovation and advancing the frontiers of medical science. With research and development being the lifeblood of biotechnology, this expansion is poised to propel XBiotech to the forefront of the industr...
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.
Sources:
Xbiotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Xbiotech Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
